London – This year, users of the well-known corticosteroid inhalers Flovent HFA or Flovent Diskus will have to look for a new medicine to manage their asthma as GlaxoSmithKline (GSK), the company that makes them has decided to stop its production. It said they would instead create an approved generic version using the same device design and composition. Doctors are …